Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Roman Šafránek"'
Autor:
Michaela Matysková Kubišová, Sylvie Dusilová Sulková, Petr Moučka, Anita Pokorná, Marcela Heislerová, Igor Guňka, Pavel Navrátil, Jaroslav Pacovský, Alena Malá, Roman Šafránek
Publikováno v:
Transplant International, Vol 37 (2024)
Patients undergoing kidney transplant are at risk of severe COVID-19. Our single-center retrospective analysis evaluated the outcomes of kidney transplant outpatients with COVID-19 who were managed with reduced immunosuppression and treatment with mo
Externí odkaz:
https://doaj.org/article/28b933caa6414910964988c5b8b95cf6
Autor:
Dana Thomasová, Michaela Zelinová, Malgorzata Libik, Jan Geryk, Pavel Votýpka, Silvie Rajnochová Bloudíčková, Karel Krejčí, Jana Reiterová, Eva Jančová, Jana Machová, Martina Kollárová, Ivan Rychík, Martin Havrda, Miroslava Horáčková, Martina Putzová, Roman Šafránek, Marek Kollár, Milan Macek
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundGenetic focal segmental glomerulosclerosis (FSGS) is caused by pathogenic variants in a broad spectrum of genes that have a variable representation based on subjects' ethnicity and/or age. The most frequently mutated autosomal recessive gen
Externí odkaz:
https://doaj.org/article/479ea1a14e1744f48660a15eb5b738b1
Autor:
Sylvie Dusilová Sulková, Jiří Horáček, Eva Vykoukalová, Roman Šafránek, Alena Malá, Vladimír Palička
Publikováno v:
Acta Medica, Vol 60, Iss 2, Pp 85-88 (2017)
We present a case of severe calciphylaxis in both thighs and calves in a patient with end-stage renal disease and advanced secondary hyperparathyroidism with successful outcome after modified therapeutic approach. The cause of calciphylaxis is multif
Externí odkaz:
https://doaj.org/article/b42fdd07f4804687a2bab71528c7a21a
Autor:
Roman Šafránek, Petr Moučka, Jaroslava Vávrová, Vladimír Palička, Ladislava Pavlíková, Sylvie Dusilová Sulková
Publikováno v:
Kidney & Blood Pressure Research, Vol 40, Iss 1, Pp 13-21 (2015)
Background/Aims: In recent years, one of technical attempts to improve biocompatibility and tolerability of the hemodialysis procedure is the substitution of acetate in dialysis solution with citrate. The aim of our study was to compare two dialysis
Externí odkaz:
https://doaj.org/article/7862f48a34dd463a9f0e21a6911b7ba7
Autor:
Sylvie Dusilová Sulková, Jiří Horáček, Roman Šafránek, Petr Gorun, Ondřej Viklický, Vladimír Palička
Publikováno v:
Acta Medica, Vol 57, Iss 1, Pp 30-33 (2014)
Denosumab is a human monoclonal antibody representing a novel therapy of osteoporosis. Contrary to always other antiosteoporotic drugs, it is not contraindicated in advanced chronic kidney disease, as its pharmacokinetic does not differ from patients
Externí odkaz:
https://doaj.org/article/08d388dadc624026a74360a597db77b4
Autor:
Adéla Tomášová, Alena Tichá, Sylvie Dusilová Sulková, Roman Safránek, Petr Moučka, Marcela Chmelařová, Ivana Baranová, Helena Párová, Zora Nývltová, Karolína Štochlová, Vladimír Palička, Ladislava Pavlíková, Zdeněk Zadák, Radomír Hyšpler
Publikováno v:
Kidney & Blood Pressure Research (2022)
Introduction: High indoxyl sulfate (IS) concentration is a serious problem for patients with CKD increasing the risk of cardiovascular diseases and CKD progression. Thus, the methods of decreasing the toxin concentrations are highly desired. The stud
Externí odkaz:
https://doaj.org/article/8d659a1f71d54fc29fb375bfd1b0ae98
Autor:
Vojtech Petr, MD, Petra Hruba, PhD, Marek Kollar, MD, Karel Krejci, MD, PhD, Roman Safranek, MD, PhD, Sona Stepankova, MD, Jarmila Dedochova, MD, Jana Machova, MD, Jakub Zieg, MD, PhD, Janka Slatinska, MD, Eva Pokorna, MD, PhD, Ondrej Viklicky, MD, PhD
Publikováno v:
Transplantation Direct, Vol 7, Iss 11, p e779 (2021)
Background. Thrombotic microangiopathy (TMA) significantly affects kidney graft survival, but its pathophysiology remains poorly understood. Methods. In this multicenter, retrospective, case–control paired study designed to control for donor-associ
Externí odkaz:
https://doaj.org/article/7ce101dd16dc40adbd4f3346063378f8
Autor:
Sylvie Dusilová Sulková, Jiří Horáček, Roman Šafránek, Petr Gorun, Ondřej Viklický, Vladimír Palička
Publikováno v:
Scopus-Elsevier
Acta Medica, Vol 57, Iss 1, Pp 30-33 (2014)
Acta Medica, Vol 57, Iss 1, Pp 30-33 (2014)
Summary: Denosumab is a human monoclonal antibody representing a novel therapy of osteoporosis. Contrary to always other antiosteoporotic drugs, it is not contraindicated in advanced chronic kidney disease, as its pharmacokinetic does not differ from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c6f6eda23eb9d38212f2f61790132ff
http://www.scopus.com/inward/record.url?eid=2-s2.0-84906955167&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84906955167&partnerID=MN8TOARS
Autor:
Roman Safranek, Michaela Kubisova, Lydia Habanova, Petr Moucka, Jakub Visek, Marta Kalousova, Miroslav Merta, Lubos Sobotka, Sylvie Dusilova Sulkova
Publikováno v:
Kidney Research and Clinical Practice, Vol 31, Iss 2, p A70 (2012)
Fetuin-A is a calcification inhibitor, negative acute phase response marker and cardiovascular mortality predictor in hemodialysis patients. Low levels of fetuin-A are associated with malnutrition, inflammation, decreased bone mass density, low-turno
Externí odkaz:
https://doaj.org/article/82d7e11f61df467c8eccf1c0b4581c6d